Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study
the Dysport in PUL study group
Physical Medicine and Rehabilitation
Research output
:
Contribution to journal
›
Article
›
peer-review
29
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Treatment Study
100%
OnabotulinumtoxinA
100%
Repeated Treatment
100%
Cerebral Palsy children
100%
Upper Limb Spasticity
100%
Home-based Exercise
30%
Therapeutic Benefits
20%
Upper Limb
20%
Repeated Cycles
20%
Treatment Goals
10%
Goal Attainment
10%
Elbow Flexion
10%
Therapeutic Program
10%
Exercise Therapy
10%
Occupational Therapy
10%
Wrist Flexors
10%
One-child
10%
Muscle Groups
10%
Treatment-related Adverse Events
10%
Physician Global Assessment
10%
Treatment Cycle
10%
Global Improvement
10%
Target muscle
10%
Treatment Difference
10%
Modified Ashworth Scale
10%
Children's Group
10%
Muscular Weakness
10%
Global Goals
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cerebral Palsy
100%
Botulinum Toxin A
100%
Spasticity
100%
Adverse Event
10%
Muscle Weakness
10%